Literature DB >> 1740666

Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells.

R Glas1, K Sturmhöfel, G J Hämmerling, K Kärre, H G Ljunggren.   

Abstract

It has frequently been suggested that loss of beta 2-microglobulin (beta 2m) in tumor cells may lead to malignant progression due to escape from immunological recognition. Here, we directly tested the role of beta 2m expression in tumorigenicity. A beta 2 m loss mutant (C4.4-25-), selected from the murine lymphoma EL-4, showed a marked reduction in tumorigenicity as compared with EL-4 in normal C57B1/6 (B6) mice. The reduced tumorigenicity was directly related to beta 2 m expression. Transfection of an intact murine beta 2m gene markedly increased the tumorigenic potential. The reduced tumorigenicity of C4.4-25- compared with beta 2m transfected cells was observed also in athymic B6 nu/nu mice, but was abolished in B6 mice depleted of natural killer (NK) 1.1-positive cells. These results show that restoration of beta 2m expression can promote tumorigenicity and demonstrate for the first time that induction of major histocompatibility complex class I expression by transfection can lead to escape from NK cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740666      PMCID: PMC2119145          DOI: 10.1084/jem.175.3.843

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.

Authors:  M Bix; N S Liao; M Zijlstra; J Loring; R Jaenisch; D Raulet
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

Review 2.  Perspectives on the role of MHC antigens in normal and malignant cell development.

Authors:  B E Elliott; D A Carlow; A M Rodricks; A Wade
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

3.  Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.

Authors:  C Ohlén; G Kling; P Höglund; M Hansson; G Scangos; C Bieberich; G Jay; K Kärre
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

4.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

5.  Altered growth of a human neuroendocrine carcinoma line after transfection of a major histocompatibility complex class I gene.

Authors:  M E Sunday; K J Isselbacher; S Gattoni-Celli; C G Willett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).

Authors:  S Gattoni-Celli; C G Willett; D B Rhoads; B Simon; R M Strauss; K Kirsch; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1. Reduction in host defense against malignancy without loss of cellular or humoral immunity.

Authors:  W E Seaman; M Sleisenger; E Eriksson; G C Koo
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

Review 8.  MHC antigen expression in colorectal tumours.

Authors:  M E Smith
Journal:  Semin Cancer Biol       Date:  1991-02       Impact factor: 15.707

9.  Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.

Authors:  P Höglund; H G Ljunggren; C Ohlén; L Ahrlund-Richter; G Scangos; C Bieberich; G Jay; G Klein; K Kärre
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Selective loss of beta 2-microglobulin mRNA in human colon carcinoma.

Authors:  F Momburg; S Koch
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  18 in total

1.  Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.

Authors:  Y Vugmeyster; R Glas; B Pérarnau; F A Lemonnier; H Eisen; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

2.  H2-M3 major histocompatibility complex class Ib-restricted CD8 T cells induced by Salmonella enterica serovar Typhimurium infection recognize proteins released by Salmonella serovar Typhimurium.

Authors:  S Ugrinovic; C G Brooks; J Robson; B A Blacklaws; C E Hormaeche; J H Robinson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  The molecular basis of natural killer (NK) cell recognition and function.

Authors:  L Moretta; M C Mingari; D Pende; C Bottino; R Biassoni; A Moretta
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

4.  Four decades of glucocorticosteroid immunosuppression.

Authors:  N R Sinclair
Journal:  CMAJ       Date:  1993-01-01       Impact factor: 8.262

5.  Expression of beta 2-microglobulin by human benign and malignant mesenchymal and neurogenic tumours.

Authors:  B L Petersen; O Braendstrup
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

6.  Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.

Authors:  F Lehmann-Grube; J Löhler; O Utermöhlen; C Gegin
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.

Authors:  R Glas; L Franksson; C Ohlén; P Höglund; B Koller; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.

Authors:  V Litwin; J Gumperz; P Parham; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

9.  Natural killer cells in non-hematopoietic malignancies.

Authors:  Mélanie Desbois; Sylvie Rusakiewicz; Clara Locher; Laurence Zitvogel; Nathalie Chaput
Journal:  Front Immunol       Date:  2012-12-24       Impact factor: 7.561

10.  In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

Authors:  H I Levitsky; A Lazenby; R J Hayashi; D M Pardoll
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.